| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Artery Disease | 19 | 2024 | 364 | 3.120 |
Why?
|
| Percutaneous Coronary Intervention | 15 | 2022 | 66 | 3.120 |
Why?
|
| Shock, Cardiogenic | 16 | 2024 | 119 | 2.760 |
Why?
|
| Cardiac Catheterization | 13 | 2022 | 307 | 2.140 |
Why?
|
| Radial Artery | 7 | 2022 | 33 | 1.850 |
Why?
|
| Acute Coronary Syndrome | 5 | 2021 | 30 | 1.820 |
Why?
|
| Heart-Assist Devices | 12 | 2024 | 807 | 1.790 |
Why?
|
| Robotic Surgical Procedures | 7 | 2023 | 319 | 1.420 |
Why?
|
| Coronary Angiography | 12 | 2024 | 243 | 1.400 |
Why?
|
| Coronary Vessels | 8 | 2024 | 192 | 1.190 |
Why?
|
| Heart Failure | 14 | 2023 | 1252 | 1.070 |
Why?
|
| Catheterization, Peripheral | 3 | 2022 | 60 | 1.070 |
Why?
|
| Hemodynamics | 7 | 2024 | 738 | 1.030 |
Why?
|
| Angioplasty, Balloon, Coronary | 11 | 2018 | 66 | 1.020 |
Why?
|
| Ischemia | 4 | 2024 | 253 | 0.960 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2023 | 191 | 0.910 |
Why?
|
| Myocardial Infarction | 10 | 2024 | 380 | 0.910 |
Why?
|
| Intra-Aortic Balloon Pumping | 4 | 2023 | 80 | 0.870 |
Why?
|
| Treatment Outcome | 38 | 2024 | 8270 | 0.850 |
Why?
|
| Registries | 5 | 2024 | 808 | 0.840 |
Why?
|
| Pulmonary Embolism | 6 | 2021 | 232 | 0.790 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2019 | 99 | 0.770 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2021 | 110 | 0.740 |
Why?
|
| Chitosan | 1 | 2021 | 17 | 0.740 |
Why?
|
| Humans | 95 | 2024 | 89924 | 0.740 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2012 | 147 | 0.730 |
Why?
|
| Drug-Eluting Stents | 5 | 2019 | 17 | 0.720 |
Why?
|
| Hemostatics | 1 | 2021 | 58 | 0.710 |
Why?
|
| Hemorrhage | 4 | 2022 | 287 | 0.710 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 3 | 2020 | 40 | 0.710 |
Why?
|
| Retrospective Studies | 37 | 2024 | 9203 | 0.690 |
Why?
|
| Blood Pressure | 2 | 2014 | 905 | 0.690 |
Why?
|
| Endoscopy | 3 | 2019 | 352 | 0.670 |
Why?
|
| Brachial Artery | 2 | 2021 | 36 | 0.670 |
Why?
|
| Kidney | 3 | 2021 | 1148 | 0.670 |
Why?
|
| Ultrasonography, Interventional | 3 | 2023 | 124 | 0.660 |
Why?
|
| Coronary Artery Bypass | 8 | 2023 | 236 | 0.600 |
Why?
|
| Disease Management | 2 | 2018 | 327 | 0.590 |
Why?
|
| Clinical Protocols | 1 | 2018 | 158 | 0.580 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2017 | 9 | 0.560 |
Why?
|
| Aortic Valve Stenosis | 4 | 2023 | 145 | 0.550 |
Why?
|
| Coronary Restenosis | 5 | 2011 | 11 | 0.540 |
Why?
|
| Aged | 41 | 2024 | 19240 | 0.530 |
Why?
|
| Upper Extremity | 1 | 2016 | 53 | 0.510 |
Why?
|
| Denervation | 1 | 2014 | 25 | 0.490 |
Why?
|
| Hypertension | 2 | 2014 | 747 | 0.480 |
Why?
|
| Male | 52 | 2024 | 42657 | 0.480 |
Why?
|
| Mammary Arteries | 3 | 2023 | 34 | 0.480 |
Why?
|
| Emergency Service, Hospital | 3 | 2021 | 528 | 0.470 |
Why?
|
| Cardiovascular System | 1 | 2014 | 63 | 0.470 |
Why?
|
| Female | 50 | 2024 | 46571 | 0.460 |
Why?
|
| Sympathectomy | 1 | 2013 | 17 | 0.450 |
Why?
|
| Hospital Mortality | 8 | 2024 | 408 | 0.440 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2013 | 72 | 0.440 |
Why?
|
| Middle Aged | 40 | 2024 | 26132 | 0.430 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2023 | 179 | 0.420 |
Why?
|
| Stents | 6 | 2024 | 412 | 0.410 |
Why?
|
| Thrombolytic Therapy | 5 | 2021 | 241 | 0.400 |
Why?
|
| Platelet Aggregation | 1 | 2012 | 44 | 0.400 |
Why?
|
| Ticlopidine | 1 | 2012 | 25 | 0.400 |
Why?
|
| Blood Coagulation Tests | 1 | 2012 | 35 | 0.400 |
Why?
|
| Blood Loss, Surgical | 1 | 2012 | 116 | 0.380 |
Why?
|
| Heart Rate | 1 | 2013 | 498 | 0.370 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 1054 | 0.370 |
Why?
|
| Myocardial Ischemia | 4 | 2024 | 162 | 0.360 |
Why?
|
| Heart Ventricles | 3 | 2021 | 786 | 0.360 |
Why?
|
| Angioplasty, Balloon | 4 | 2020 | 98 | 0.360 |
Why?
|
| Aorta | 3 | 2021 | 289 | 0.360 |
Why?
|
| Vascular Patency | 5 | 2023 | 129 | 0.350 |
Why?
|
| Chest Pain | 1 | 2010 | 42 | 0.350 |
Why?
|
| Popliteal Artery | 2 | 2020 | 28 | 0.350 |
Why?
|
| Absorbable Implants | 2 | 2020 | 35 | 0.340 |
Why?
|
| Coronary Disease | 4 | 2018 | 260 | 0.340 |
Why?
|
| Heart Arrest | 3 | 2018 | 278 | 0.330 |
Why?
|
| Ventricular Function, Left | 4 | 2021 | 613 | 0.320 |
Why?
|
| Heart Diseases | 2 | 2016 | 302 | 0.320 |
Why?
|
| Peripheral Arterial Disease | 2 | 2020 | 96 | 0.320 |
Why?
|
| Risk Factors | 12 | 2024 | 5554 | 0.300 |
Why?
|
| Time Factors | 14 | 2021 | 5357 | 0.300 |
Why?
|
| Gastric Fundus | 1 | 2006 | 7 | 0.280 |
Why?
|
| Gastric Fistula | 1 | 2006 | 5 | 0.280 |
Why?
|
| Electrodes | 1 | 2006 | 88 | 0.270 |
Why?
|
| Pericardium | 1 | 2006 | 70 | 0.270 |
Why?
|
| Septal Occluder Device | 4 | 2021 | 45 | 0.260 |
Why?
|
| Aortic Valve | 3 | 2023 | 245 | 0.260 |
Why?
|
| Follow-Up Studies | 10 | 2022 | 3680 | 0.250 |
Why?
|
| Calcium Channel Blockers | 1 | 2005 | 121 | 0.250 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2019 | 222 | 0.240 |
Why?
|
| Defibrillators, Implantable | 1 | 2006 | 146 | 0.240 |
Why?
|
| Cardiovascular Agents | 2 | 2019 | 55 | 0.240 |
Why?
|
| Brachiocephalic Veins | 2 | 2021 | 34 | 0.240 |
Why?
|
| Triage | 2 | 2018 | 117 | 0.230 |
Why?
|
| Anticoagulants | 3 | 2022 | 431 | 0.230 |
Why?
|
| Echocardiography, Three-Dimensional | 4 | 2019 | 518 | 0.230 |
Why?
|
| Carotid Arteries | 1 | 2024 | 135 | 0.220 |
Why?
|
| Fibrinolytic Agents | 3 | 2021 | 227 | 0.220 |
Why?
|
| Cysteine | 1 | 2024 | 137 | 0.220 |
Why?
|
| Hypothermia, Induced | 1 | 2024 | 82 | 0.220 |
Why?
|
| Coronary Stenosis | 2 | 2019 | 39 | 0.210 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2015 | 132 | 0.210 |
Why?
|
| Kidney Diseases | 1 | 2005 | 320 | 0.210 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2022 | 14 | 0.210 |
Why?
|
| Microcirculation | 2 | 2024 | 105 | 0.200 |
Why?
|
| Foreign-Body Migration | 2 | 2017 | 39 | 0.200 |
Why?
|
| Echocardiography, Transesophageal | 5 | 2019 | 348 | 0.200 |
Why?
|
| Ulnar Artery | 1 | 2022 | 5 | 0.200 |
Why?
|
| Coronary Circulation | 2 | 2024 | 131 | 0.200 |
Why?
|
| Femoral Artery | 3 | 2022 | 84 | 0.200 |
Why?
|
| Device Removal | 2 | 2018 | 168 | 0.200 |
Why?
|
| Pilot Projects | 2 | 2024 | 871 | 0.200 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 29 | 0.190 |
Why?
|
| Hemostasis | 1 | 2021 | 21 | 0.190 |
Why?
|
| Hemostatic Techniques | 1 | 2021 | 18 | 0.190 |
Why?
|
| Troponin T | 1 | 2021 | 39 | 0.180 |
Why?
|
| Arteriovenous Fistula | 1 | 2021 | 53 | 0.180 |
Why?
|
| Foramen Ovale, Patent | 1 | 2021 | 18 | 0.180 |
Why?
|
| Prosthesis Design | 5 | 2024 | 299 | 0.180 |
Why?
|
| Heart Atria | 3 | 2021 | 282 | 0.180 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2020 | 22 | 0.180 |
Why?
|
| Predictive Value of Tests | 7 | 2021 | 1731 | 0.170 |
Why?
|
| Length of Stay | 3 | 2019 | 748 | 0.170 |
Why?
|
| Survival Rate | 5 | 2024 | 1898 | 0.170 |
Why?
|
| Sutureless Surgical Procedures | 1 | 2019 | 6 | 0.160 |
Why?
|
| Everolimus | 1 | 2019 | 35 | 0.160 |
Why?
|
| Stroke Volume | 2 | 2021 | 479 | 0.160 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2019 | 69 | 0.160 |
Why?
|
| Perioperative Care | 1 | 2021 | 171 | 0.160 |
Why?
|
| Prosthesis Implantation | 1 | 2020 | 129 | 0.160 |
Why?
|
| Atherectomy, Coronary | 1 | 2018 | 2 | 0.160 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 256 | 0.160 |
Why?
|
| Cardiac Catheters | 1 | 2018 | 13 | 0.160 |
Why?
|
| Electrocardiography | 2 | 2011 | 497 | 0.160 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2020 | 145 | 0.150 |
Why?
|
| Renal Dialysis | 1 | 2021 | 337 | 0.150 |
Why?
|
| Prognosis | 5 | 2020 | 3796 | 0.150 |
Why?
|
| Hospital Costs | 1 | 2019 | 109 | 0.150 |
Why?
|
| Adult | 11 | 2024 | 26810 | 0.150 |
Why?
|
| Monocytes | 1 | 2019 | 221 | 0.150 |
Why?
|
| Social Determinants of Health | 1 | 2019 | 103 | 0.150 |
Why?
|
| Microvessels | 1 | 2018 | 69 | 0.150 |
Why?
|
| Heart Transplantation | 1 | 2023 | 730 | 0.150 |
Why?
|
| Vascular Calcification | 1 | 2018 | 51 | 0.150 |
Why?
|
| Catheters | 3 | 2023 | 85 | 0.140 |
Why?
|
| Blood Circulation | 1 | 2017 | 30 | 0.140 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2019 | 93 | 0.140 |
Why?
|
| Heart Massage | 1 | 2017 | 12 | 0.140 |
Why?
|
| United States | 9 | 2024 | 7102 | 0.140 |
Why?
|
| Renal Veins | 1 | 2017 | 28 | 0.140 |
Why?
|
| Computer Simulation | 1 | 2021 | 1102 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2019 | 191 | 0.140 |
Why?
|
| Severity of Illness Index | 8 | 2019 | 1859 | 0.140 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 168 | 0.140 |
Why?
|
| Equipment Failure | 3 | 2018 | 122 | 0.140 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2017 | 55 | 0.130 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 290 | 0.130 |
Why?
|
| Biomarkers | 2 | 2021 | 1775 | 0.130 |
Why?
|
| Survival Analysis | 2 | 2017 | 1497 | 0.130 |
Why?
|
| Risk Assessment | 8 | 2020 | 2327 | 0.130 |
Why?
|
| Organ Dysfunction Scores | 1 | 2016 | 27 | 0.130 |
Why?
|
| Macrophages | 1 | 2019 | 582 | 0.130 |
Why?
|
| Rest | 1 | 2016 | 49 | 0.130 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2016 | 47 | 0.130 |
Why?
|
| Catheterization | 1 | 2017 | 237 | 0.130 |
Why?
|
| Vena Cava Filters | 1 | 2017 | 98 | 0.120 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 145 | 0.120 |
Why?
|
| Atrial Fibrillation | 2 | 2021 | 357 | 0.120 |
Why?
|
| Atrial Appendage | 1 | 2015 | 33 | 0.120 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2019 | 480 | 0.120 |
Why?
|
| Forecasting | 1 | 2014 | 304 | 0.110 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2006 | 99 | 0.110 |
Why?
|
| Thrombosis | 1 | 2016 | 302 | 0.110 |
Why?
|
| Age Factors | 4 | 2021 | 1880 | 0.110 |
Why?
|
| Software | 1 | 2017 | 669 | 0.100 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2013 | 62 | 0.100 |
Why?
|
| Epigastric Arteries | 1 | 2012 | 9 | 0.100 |
Why?
|
| Catheter Ablation | 1 | 2015 | 254 | 0.100 |
Why?
|
| Whole Blood Coagulation Time | 1 | 2012 | 7 | 0.100 |
Why?
|
| Academic Medical Centers | 3 | 2021 | 384 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 691 | 0.100 |
Why?
|
| Prevalence | 3 | 2024 | 1250 | 0.100 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 6780 | 0.100 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 2767 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2012 | 118 | 0.090 |
Why?
|
| Vascular Resistance | 2 | 2024 | 105 | 0.090 |
Why?
|
| Mitral Valve | 1 | 2013 | 264 | 0.090 |
Why?
|
| Prospective Studies | 6 | 2022 | 4325 | 0.090 |
Why?
|
| Point-of-Care Systems | 1 | 2012 | 146 | 0.090 |
Why?
|
| Punctures | 2 | 2021 | 30 | 0.090 |
Why?
|
| Acute Disease | 2 | 2024 | 846 | 0.090 |
Why?
|
| Platelet Activation | 1 | 2010 | 14 | 0.090 |
Why?
|
| Coronary Aneurysm | 1 | 2010 | 16 | 0.090 |
Why?
|
| Mammaplasty | 1 | 2012 | 110 | 0.090 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 265 | 0.090 |
Why?
|
| Thoracic Injuries | 1 | 2010 | 38 | 0.090 |
Why?
|
| Surgical Flaps | 1 | 2012 | 250 | 0.090 |
Why?
|
| Sirolimus | 1 | 2010 | 162 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2017 | 2677 | 0.080 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 3 | 2003 | 11 | 0.080 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2010 | 113 | 0.080 |
Why?
|
| Medically Uninsured | 1 | 2009 | 64 | 0.080 |
Why?
|
| Paclitaxel | 1 | 2010 | 474 | 0.080 |
Why?
|
| Minority Groups | 1 | 2009 | 147 | 0.070 |
Why?
|
| Illinois | 4 | 2018 | 485 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2019 | 841 | 0.070 |
Why?
|
| Pulsatile Flow | 2 | 2021 | 51 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2011 | 436 | 0.070 |
Why?
|
| Patient Compliance | 1 | 2009 | 230 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2011 | 457 | 0.070 |
Why?
|
| Chicago | 3 | 2021 | 1431 | 0.070 |
Why?
|
| Sex Factors | 2 | 2021 | 1075 | 0.070 |
Why?
|
| Thoracotomy | 1 | 2006 | 64 | 0.070 |
Why?
|
| Postoperative Complications | 3 | 2022 | 2313 | 0.070 |
Why?
|
| Saphenous Vein | 1 | 2006 | 61 | 0.060 |
Why?
|
| Brachytherapy | 2 | 2004 | 120 | 0.060 |
Why?
|
| Embolism | 1 | 2006 | 33 | 0.060 |
Why?
|
| Beta Particles | 2 | 2003 | 4 | 0.060 |
Why?
|
| Strontium Radioisotopes | 2 | 2003 | 4 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 979 | 0.060 |
Why?
|
| Radiography, Thoracic | 1 | 2006 | 324 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2019 | 958 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 2 | 2019 | 466 | 0.060 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2019 | 258 | 0.060 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2015 | 103 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2006 | 236 | 0.060 |
Why?
|
| Angina, Unstable | 1 | 2003 | 6 | 0.060 |
Why?
|
| Comorbidity | 2 | 2019 | 953 | 0.060 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2003 | 30 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3470 | 0.060 |
Why?
|
| Extremities | 1 | 2024 | 173 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2023 | 110 | 0.050 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2003 | 27 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2019 | 865 | 0.050 |
Why?
|
| Spasm | 1 | 2022 | 17 | 0.050 |
Why?
|
| Sternotomy | 1 | 2022 | 24 | 0.050 |
Why?
|
| Blood Coagulation | 1 | 2022 | 91 | 0.050 |
Why?
|
| Myocardial Revascularization | 3 | 2009 | 30 | 0.050 |
Why?
|
| Multivariate Analysis | 3 | 2011 | 983 | 0.050 |
Why?
|
| Pulmonary Veins | 1 | 2002 | 93 | 0.050 |
Why?
|
| Ventricular Pressure | 1 | 2021 | 41 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1864 | 0.050 |
Why?
|
| Pulmonary Artery | 1 | 2023 | 323 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2021 | 88 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2002 | 234 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2021 | 200 | 0.050 |
Why?
|
| Torsion, Mechanical | 1 | 2020 | 6 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2021 | 222 | 0.040 |
Why?
|
| Limb Salvage | 1 | 2020 | 35 | 0.040 |
Why?
|
| Pulmonary Valve | 1 | 2020 | 34 | 0.040 |
Why?
|
| Cardiac Output | 1 | 2020 | 155 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 277 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2023 | 504 | 0.040 |
Why?
|
| Organ Size | 1 | 2020 | 372 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2019 | 127 | 0.040 |
Why?
|
| Bioprosthesis | 1 | 2019 | 39 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 1469 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 154 | 0.040 |
Why?
|
| Retreatment | 1 | 2018 | 107 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2019 | 230 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 303 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2020 | 682 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 3021 | 0.040 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2019 | 144 | 0.040 |
Why?
|
| Operative Time | 1 | 2018 | 147 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 222 | 0.040 |
Why?
|
| Hospitalization | 1 | 2023 | 888 | 0.040 |
Why?
|
| Reoperation | 1 | 2020 | 604 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2019 | 466 | 0.040 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 266 | 0.040 |
Why?
|
| Prosthesis Fitting | 1 | 2017 | 16 | 0.040 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 241 | 0.040 |
Why?
|
| Incidence | 3 | 2010 | 1601 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 603 | 0.040 |
Why?
|
| Equipment Design | 1 | 2018 | 422 | 0.040 |
Why?
|
| Phlebography | 1 | 2017 | 69 | 0.030 |
Why?
|
| Patient Selection | 1 | 2020 | 682 | 0.030 |
Why?
|
| Oxygen | 1 | 2021 | 745 | 0.030 |
Why?
|
| Cannula | 1 | 2016 | 50 | 0.030 |
Why?
|
| Health Status | 1 | 2018 | 371 | 0.030 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2003 | 227 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2016 | 296 | 0.030 |
Why?
|
| Purines | 1 | 2016 | 93 | 0.030 |
Why?
|
| Animals | 1 | 2014 | 27526 | 0.030 |
Why?
|
| Echocardiography | 1 | 2020 | 944 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2016 | 150 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1704 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2009 | 591 | 0.030 |
Why?
|
| Contrast Media | 1 | 2019 | 1084 | 0.030 |
Why?
|
| Models, Biological | 1 | 2021 | 1765 | 0.030 |
Why?
|
| Recurrence | 2 | 2009 | 1145 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2017 | 565 | 0.030 |
Why?
|
| Adenosine | 1 | 2016 | 240 | 0.030 |
Why?
|
| Heart Valve Prosthesis | 1 | 2013 | 98 | 0.030 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2013 | 113 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 2018 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2015 | 720 | 0.030 |
Why?
|
| Reference Values | 1 | 2013 | 662 | 0.020 |
Why?
|
| Angina Pectoris | 1 | 2011 | 29 | 0.020 |
Why?
|
| Workflow | 1 | 2011 | 81 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 358 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2013 | 395 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2011 | 312 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 2010 | 98 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 6408 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 221 | 0.020 |
Why?
|
| Algorithms | 1 | 2017 | 1908 | 0.020 |
Why?
|
| Violence | 1 | 2010 | 153 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 855 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 434 | 0.020 |
Why?
|
| Preventive Medicine | 1 | 2006 | 18 | 0.020 |
Why?
|
| Logistic Models | 1 | 2009 | 1214 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2006 | 153 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 2004 | 37 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 151 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 2004 | 69 | 0.010 |
Why?
|
| Endpoint Determination | 1 | 2003 | 55 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2003 | 278 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 234 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 2002 | 90 | 0.010 |
Why?
|
| Angiography | 1 | 2002 | 208 | 0.010 |
Why?
|
| Radiography | 1 | 2004 | 808 | 0.010 |
Why?
|
| Random Allocation | 1 | 2002 | 327 | 0.010 |
Why?
|
| Vascular Surgical Procedures | 1 | 2002 | 149 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2006 | 2887 | 0.010 |
Why?
|
| Adolescent | 1 | 2010 | 9339 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 1134 | 0.010 |
Why?
|